Investors’ Timeline to Sue Grows in New Opioid Ruling (Podcast)

Investors may have a lot more opportunity to sue their boards of directors for mismanagement after a ruling last month in a Delaware opioid case.

_{Listen here and subscribe to On The Merits on Apple Podcasts, Spotify, Google Podcasts, Megaphone, or Audible.}

The ruling from Delaware Chancery Court, the country’s premiere venue for corporate law disputes, was in a case against drug wholesaler AmerisourceBergen that centered on allegations its reckless opioid selling damaged the company’s stock price. The court found that investors can introduce evidence of mismanagement dating back years—a much longer ...